Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis

ClinicalTrials.gov ID: NCT02931838

Public ClinicalTrials.gov record NCT02931838. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase 2 Study to Evaluate the Clinical Efficacy and Safety of BMS-986165 in Subjects With Moderate to Severe Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Study to evaluate efficacy and safety in subjects with moderate to severe Psoriasis treated with BMS-986165

Study identification

NCT ID
NCT02931838
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
268 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 15, 2016 (Actual)
Primary completion
Nov 16, 2017 (Actual)
Completion
Nov 16, 2017 (Actual)
Last update posted
Nov 27, 2020

2016 – 2017

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
University of California Irvine Irvine California 92697 —
University of California San Diego San Diego California 92122 —
Renstar Medical Research Ocala Florida 34471 —
Dermatologic Surgery Specialists, PC Macon Georgia 31217 —
PMG Research of Christie Clinic, LLC Champaign Illinois 61820 —
NorthShore University Health System Skokie Illinois 60077 —
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256 —
Dartmouth-Hitchcock Medical Center-Norris Cotton Cancer Center Lebanon New Hampshire 03756 —
Piedmont Plastic Surgery & Dermatology - Charlotte/Blakeney Location Charlotte North Carolina 28277 —
PMG Research of Rocky Mount, LLC Rocky Mount North Carolina 27804 —
PMG Research of Wilmington, PLC Wilmington North Carolina 28401 —
Central Sooner Research Norman Oklahoma 73071 —
Health Concepts Rapid City South Dakota 57702 —
Rivergate Dermatology Clinical Research Center, Pllc Goodlettsville Tennessee 37072 —
Local Institution Knoxville Tennessee 37920 —
Austin Dermatology Associates Austin Texas 78705 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02931838, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 27, 2020 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02931838 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →